UBS ASSET MANAGEMENT AMERICAS INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$167,2350.0%110,7520.0%0.00%
Q1 2023$167,235
-39.6%
110,7520.0%0.00%
Q4 2022$276,882
-99.9%
110,7520.0%0.00%
Q3 2022$467,374,000
+51.3%
110,7520.0%0.00%
Q2 2022$308,998,000
-51.2%
110,7520.0%0.00%
Q1 2022$633,502,000
-37.5%
110,752
-0.2%
0.00%
Q4 2021$1,013,504,000
-3.2%
111,008
+13.3%
0.00%
Q3 2021$1,046,968,000
-34.7%
97,939
-5.3%
0.00%
-100.0%
Q2 2021$1,604,458,000
+0.4%
103,380
+4.9%
0.00%0.0%
Q1 2021$1,597,804,000
-20.0%
98,569
+4.4%
0.00%0.0%
Q4 2020$1,997,934,000
+42.8%
94,3980.0%0.00%0.0%
Q3 2020$1,398,978,000
+5.5%
94,398
+4.7%
0.00%0.0%
Q2 2020$1,325,725,000
+24.0%
90,124
-1.0%
0.00%0.0%
Q1 2020$1,068,833,000
-50.1%
91,042
-0.1%
0.00%0.0%
Q4 2019$2,141,675,000
+29.9%
91,135
+2.2%
0.00%0.0%
Q3 2019$1,649,221,000
+34.7%
89,147
+35.4%
0.00%0.0%
Q2 2019$1,224,319,000
-13.0%
65,859
+14.4%
0.00%0.0%
Q1 2019$1,407,230,000
+13.0%
57,579
+19.9%
0.00%0.0%
Q4 2018$1,245,847,000
-1.0%
48,028
+20.7%
0.00%0.0%
Q3 2018$1,259,037,000
-4.9%
39,780
+16.8%
0.00%0.0%
Q2 2018$1,323,620,000
+83.7%
34,070
+30.5%
0.00%0.0%
Q1 2018$720,442,000
+213.4%
26,103
+105.5%
0.00%
Q4 2017$229,870,000
+87636.6%
12,700
-16.4%
0.00%
Q3 2016$262,000
-4.4%
15,2000.0%0.00%
Q2 2016$274,000
-5.2%
15,2000.0%0.00%
Q1 2016$289,000
-28.8%
15,2000.0%0.00%
Q4 2015$406,00015,2000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders